https://scholars.lib.ntu.edu.tw/handle/123456789/536669
標題: | Joint effects of N-terminal pro-B-type-natriuretic peptide and C-reactive protein vs angiographic severity in predicting major adverse cardiovascular events and clinical restenosis after coronary angioplasty in patients with stable coronary artery disease | 作者: | Dai D.-F. HWANG, JUEY-JEN JIUNN-LEE LIN JOU-WEI LIN Hsu C.-N. Lin C.-M. FU-TIEN CHIANG LING-PING LAI Hsu K.-L. Tseng C.-D. Tseng Y.-Z. |
公開日期: | 2008 | 卷: | 72 | 期: | 8 | 起(迄)頁: | 1316-1323 | 來源出版物: | Circulation Journal | 摘要: | Background: This study was designed to evaluate the joint effects of plasma C-reactive protein (CRP) and N-terminal pro-B-type natriuretic peptide (NT-proBNP) vs coronary angiographic severity on cardiovascular risk stratification. Methods and Results: A total of 345 patients with stable coronary artery disease (CAD) were recruited after successful percutaneous coronary intervention (PCI). Endpoints were major adverse cardiovascular events (MACE) and cumulative clinical restenosis rate after 18-36-month follow-up. Plasma NT-proBNP and CRP levels were among the strongest predictors of MACE. Adjusted hazard ratios of MACE according to combined biomarkers were 2.4 (p=0.05) for elevated CRP only, 5.22 (p<0.001) for elevated NT-proBNP only, and 7.04 (p<0.001) for elevation of both. The differential capacity using both plasma CRP and NT-proBNP in a receiver-operating-characteristics curve analysis (area under curve, AUC: 0.82) was significantly higher than using eiflier biomarker alone or conventional risk factors (AUC: 0.67). Significant predictors of clinical restenosis were plasma NT-proBNP and the Gensini score. The combination of NT-proBNP and the Gensini score was the strongest predictor (AUC: 0.77) for clinical restenosis. Conclusions: Plasma NT-proBNP, CRP, and the Gensini score are complementary in risk stratification. Combined use of these biomarkers has provided substantial extra information to conventional risk factors in stable CAD patients. |
URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-48749130793&doi=10.1253%2fcircj.72.1316&partnerID=40&md5=40f3b56df94714bfbfe0a087036f0ac5 https://scholars.lib.ntu.edu.tw/handle/123456789/536669 |
ISSN: | 1346-9843 | DOI: | 10.1253/circj.72.1316 | SDG/關鍵字: | amino terminal pro brain natriuretic peptide; biological marker; C reactive protein; adult; aged; angiocardiography; article; cardiovascular disease; cardiovascular risk; coronary artery disease; disease severity; female; gensini score; human; major clinical study; male; restenosis; risk assessment; risk factor; scoring system; transluminal coronary angioplasty; Aged; Angioplasty, Transluminal, Percutaneous Coronary; Biological Markers; C-Reactive Protein; Cardiovascular Diseases; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Disease-Free Survival; Female; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Predictive Value of Tests; Prospective Studies; Risk Assessment; Risk Factors; ROC Curve; Severity of Illness Index; Time Factors |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。